Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Larimar Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Larimar Therapeutics Inc. May 19, 202688.6%
-
Spero Therapeutics Inc. June 12, 202598.3%
-
Larimar Therapeutics Inc. May 9, 202377.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 23, 2026 | Spero Therapeutics Inc. | Grant or award | +10,000 | — | — |
| Feb 27, 2026 | Larimar Therapeutics Inc. | Open-market purchase | +5,000 | $5.00 | $25,000 |
| Jun 12, 2025 | Spero Therapeutics Inc. | Grant or award | +20,000 | — | — |
| May 29, 2024 | Spero Therapeutics Inc. | Grant or award | +20,000 | — | — |
| Feb 14, 2024 | Larimar Therapeutics Inc. | Open-market purchase | +2,000 | $11.00 | $22,000 |
| Oct 5, 2023 | Spero Therapeutics Inc. | Grant or award | +20,000 | — | — |
Questions about Frank E. Thomas
What boards is Frank E. Thomas on?
Frank E. Thomas sits on the boards of Larimar Therapeutics Inc. and Spero Therapeutics Inc.
How long has Frank E. Thomas served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.